Quick Answer
NP Life Sciences Health Industry Group Inc. reported Net Income Loss of -$2.9 thousand for the year ending 2023.
- NP Life Sciences Health Industry Group Inc. showed an increase of +84.4% in Net Income Loss from 2022 to 2023.
- This data is from NP Life Sciences Health Industry Group Inc.'s annual report (Form 10-K), filed with the SEC on April 16, 2024.
- XBRL data for this metric is available from 2018 to 2023 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$29.7 thousand | Q2 2019: -$5.0 thousand | Q3 2019: -$31.9 thousand | Q1 2020: -$30.1 thousand | Q2 2020: -$53.7 thousand | Q3 2020: -$25.6 thousand | Q1 2021: -$24.2 thousand | Q2 2021: -$52.7 thousand | Q3 2021: -$20.8 thousand | Q1 2022: -$31.1 thousand | Q2 2022: $1.1 thousand | Q3 2022: -$5.4 thousand | Q1 2023: $1.2 thousand | Q2 2023: $71.2 thousand | Q3 2023: -$37.7 thousand.
- Over the full 6 years of available data (2018 to 2023), NP Life Sciences Health Industry Group Inc.'s Net Income Loss has grown by 85.9%.
- Historical annual values: Fiscal year 2023: -$2.9 thousand | Fiscal year 2022: -$18.9 thousand | Fiscal year 2021: -$65.7 thousand | Fiscal year 2020: -$131.1 thousand | Fiscal year 2019: -$108.8 thousand | Fiscal year 2018: -$20.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: